Sallyport Commercial Finance provided $2 million for a developer of optical equipment and corneal topography technology.
This funding comprises cash flow loans and inventory finance as the business sets its sights on accelerating domestic revenue, achieving financial stability and further advancing its research and development endeavors.
The infusion of funds from Sallyport will provide the client with a tailored accounts receivable facility and strategic financing, which will enable the company to expand its domestic operations, increase revenue streams and achieve financial sustainability. It will also fuel further research and development initiatives, allowing the client to continue pushing the boundaries of optical technology.
One notable aspect of the funding is its enablement of international sales. The client intends to leverage the facility to facilitate sales to unrelated entities abroad, backed by comprehensive insurance coverage. This international expansion strategy underscores the company’s commitment to global growth and market penetration.
“Having been experts in the ophthalmic field for many years, we are excited to help our client deliver their innovative new ophthalmic technology and equipment to a wide range of optical physicians both in practice, in education at home and overseas,” Nick Hart, president of Sallyport, said. “Their technology represents a huge step forward in the diagnosis and resolution of a wide range of patient conditions.”
